Tianwang Buxin Dan regulated PI3K/Akt/mTOR signaling pathway to improve constipation and emotional disorders in rats
- 1Department of Anorectal Surgery, The Affiliated Hospital of Nanjing University of Chinese Medicine , , ,
Abstract
Background
Functional constipation (FC) is frequently comorbid with anxiety and depression, yet pharmacological strategies targeting both gastrointestinal and emotional symptoms remain limited. This study investigated the therapeutic effects and molecular mechanisms of Tianwang Buxin Dan (TWBXD), a classical Chinese herbal formula, in treating FC with emotional disturbances using an integrated strategy combining network pharmacology, molecular docking, and in vivo validation.Methods
TWBXD chemical constituents were characterized exclusively by UHPLC-MS/MS, yielding 650 compounds for network pharmacology. Targets were predicted via TargetNet and intersected with disease-associated genes from GeneCards. Common targets underwent PPI network analysis, GO/KEGG enrichment, and molecular docking. In vivo, a rat model was established by CUMS plus diphenoxylate and treated with TWBXD (low, medium, high doses) or positive drugs (mosapride plus fluoxetine) for 28 days. Therapeutic effects and pathway regulation in colon and hippocampus were evaluated by behavioral tests, gastrointestinal function assessment, histopathology, transmission electron microscopy, Western blotting, and qPCR.Results
Network pharmacology identified 473 drug targets and 308 disease-overlapping targets. KEGG enrichment highlighted PI3K-Akt, MAPK, IL-17, and neuroactive ligand-receptor interaction pathways, while PPI analysis identified Akt1, IL-6, and TNF as hub genes. Molecular docking showed quercetin, luteolin, and tanshinone IIA bound stably to Akt1, IL-6, and JUN (binding energies ≤ -6.6 kcal/mol). In vivo, TWBXD dose-dependently improved fecal water content, intestinal transit, sucrose preference, and open-field performance, and attenuated colonic mucosal injury, hippocampal neuronal damage, and mitochondrial disruption. Mechanistically, TWBXD was associated with increased PI3K/Akt/mTOR phosphorylation in colonic and hippocampal tissues and with reduced JNK expression in the hippocampus. No organ toxicity was observed.Conclusion
TWBXD alleviates constipation-related gastrointestinal dysfunction and comorbid anxiety/depression-like behaviors in rats, and these effects are associated with activation of PI3K/Akt/mTOR signaling in colonic and hippocampal tissues and with modulation of JNK signaling in the hippocampus. Although the concordance between computational predictions and multi-level in vivo validation supports TWBXD as a multi-target therapeutic candidate for functional constipation with emotional comorbidities, the causal contribution of PI3K/Akt/mTOR signaling, and the extent to which the peripheral and central changes are functionally coupled through the gut-brain axis, remain to be established.
Related
- Association between psychiatric disorders and constipation : A population-based cross-sectional study
- Electrophysiological reactivity to emotional images and targets predicts the development of substance use disorders in adolescent girls
- PLPP1 inhibits Wnt/β-catenin signaling via enhancing Caveolin-1/β-catenin interaction and is negatively regulated by c-Myc in osteosarcoma
- Efficacy of a personalized, response-based transdiagnostic intervention for emotional disorders delivered via the Internet: a protocol for an adaptive randomized controlled trial
- Acupuncture combined with transcutaneous auricular vagus nerve stimulation for chronic postpartum insomnia comorbid with emotional disorders: a case report
BibTeX
@article{wang2026tianwang,
title = {{Tianwang Buxin Dan regulated PI3K/Akt/mTOR signaling pathway to improve constipation and emotional disorders in rats}},
author = {Heng Wang and Xinran Li and Zhaoyu Chen and Li Ji and Shaoliang Li and Haihua Qian and Dan Zhang},
journal = {Frontiers in medicine},
year = {2026},
month = oct,
doi = {10.3389/fmed.2026.1942569},
url = {https://europepmc.org/article/PMC/PMC13717440},
note = {CC BY},
}
RIS
TY - JOUR
TI - Tianwang Buxin Dan regulated PI3K/Akt/mTOR signaling pathway to improve constipation and emotional disorders in rats
AU - Heng Wang
AU - Xinran Li
AU - Zhaoyu Chen
AU - Li Ji
AU - Shaoliang Li
AU - Haihua Qian
AU - Dan Zhang
PY - 2026
DA - 2026/10/14
JO - Frontiers in medicine
DO - 10.3389/fmed.2026.1942569
UR - https://europepmc.org/article/PMC/PMC13717440
AB - Background Functional constipation (FC) is frequently comorbid with anxiety and depression, yet pharmacological strategies targeting both gastrointestinal and emotional symptoms remain limited. This study investigated the therapeutic effects and molecular mechanisms of Tianwang Buxin Dan (TWBXD), a classical Chinese herbal formula, in treating FC with emotional disturbances using an integrated strategy combining network pharmacology, molecular docking, and in vivo validation.Methods TWBXD chemical constituents were characterized exclusively by UHPLC-MS/MS, yielding 650 compounds for network pharmacology. Targets were predicted via TargetNet and intersected with disease-associated genes from GeneCards. Common targets underwent PPI network analysis, GO/KEGG enrichment, and molecular docking. In vivo, a rat model was established by CUMS plus diphenoxylate and treated with TWBXD (low, medium, high doses) or positive drugs (mosapride plus fluoxetine) for 28 days. Therapeutic effects and pathway regulation in colon and hippocampus were evaluated by behavioral tests, gastrointestinal function assessment, histopathology, transmission electron microscopy, Western blotting, and qPCR.Results Network pharmacology identified 473 drug targets and 308 disease-overlapping targets. KEGG enrichment highlighted PI3K-Akt, MAPK, IL-17, and neuroactive ligand-receptor interaction pathways, while PPI analysis identified Akt1, IL-6, and TNF as hub genes. Molecular docking showed quercetin, luteolin, and tanshinone IIA bound stably to Akt1, IL-6, and JUN (binding energies ≤ -6.6 kcal/mol). In vivo, TWBXD dose-dependently improved fecal water content, intestinal transit, sucrose preference, and open-field performance, and attenuated colonic mucosal injury, hippocampal neuronal damage, and mitochondrial disruption. Mechanistically, TWBXD was associated with increased PI3K/Akt/mTOR phosphorylation in colonic and hippocampal tissues and with reduced JNK expression in the hippocampus. No organ toxicity was observed.Conclusion TWBXD alleviates constipation-related gastrointestinal dysfunction and comorbid anxiety/depression-like behaviors in rats, and these effects are associated with activation of PI3K/Akt/mTOR signaling in colonic and hippocampal tissues and with modulation of JNK signaling in the hippocampus. Although the concordance between computational predictions and multi-level in vivo validation supports TWBXD as a multi-target therapeutic candidate for functional constipation with emotional comorbidities, the causal contribution of PI3K/Akt/mTOR signaling, and the extent to which the peripheral and central changes are functionally coupled through the gut-brain axis, remain to be established.
SN - 2296-858X
ER -